Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Ioannina – page 6

185 clinical trials in Ioannina, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.

Ioannina at a glance
185
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

185 trials in Ioannina

Open in trial search

Myelofibrosis

Recruiting

Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Navtemadlin
  • Sponsor:Kartos Therapeutics Inc.

Sepsis

Recruiting

Study on Early Clarithromycin Treatment to Prevent Sepsis in Patients with Community-Acquired Pneumonia

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Clarithromycin
  • Sponsor:Hellenic Institute For The Study Of Sepsis

Study on the Long-Term Safety of Finerenone with ACE Inhibitors or ARBs for Children and Young Adults with Chronic Kidney Disease and Proteinuria

InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Pfizer Inc.

Myelofibrosis+1

Recruiting

Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Aprepitant
  • Sponsor:Karyopharm Therapeutics Inc.

Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Merck Sharp & Dohme LLC

Thalassaemia beta+2

Recruiting

Study of SP-420 for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:18–64 years
  • Substances:(S)-4,5-Dihydro-2-[2-Hydroxy-4-(3,6-Dioxaheptyloxy)Phenyl]-4-Methyl-4-Thiazolecarboxylic Acid
  • Sponsor:Pharmacosmos A/S

Study on the Effects of Iptacopan in Patients with Idiopathic Membranoproliferative Glomerulonephritis (IC-MPGN)

Investigational
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG

Study on Anakinra for Patients with Long COVID and Ongoing Respiratory Symptoms

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Hellenic Institute For The Study Of Sepsis

Study on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Universitaet Des Saarlandes
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB

Chronic kidney disease

Not yet recruiting

Phase III Randomized Study of Balcinrenone and Dapagliflozin Versus Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease Stage 3b‑4

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Ioannina

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking trials focusing on heart failure prevention and innovative treatments for cardiovascular diseases. Studies evaluating new combination therapies and investigating methods to reduce cardiovascular risks.

  • Heart Failure Prevention
  • Cardiovascular Disease Management
  • Deep Vein Thrombosis

Multiple trials exploring the effectiveness of novel medications in reducing cardiovascular events and improving patient outcomes.

02 Metabolic Disorders

Innovative research targeting obesity and various forms of hypercholesterolemia. Studies include treatments for both adult and pediatric patients with metabolic conditions.

  • Obesity Management
  • Dyslipidemia Treatment
  • Familial Hypercholesterolemia

Clinical investigations focusing on new therapeutic approaches for managing metabolic disorders and their complications.

03 Respiratory Medicine

Advanced studies in asthma and pulmonary fibrosis treatment. Research evaluating new medications for improving lung function and managing severe respiratory conditions.

  • Asthma Control
  • Pulmonary Fibrosis
  • Viral Lung Infections

Trials examining innovative therapies for both acute and chronic respiratory conditions.

04 Hematology

Research focusing on sickle cell disease and beta-thalassemia. Studies evaluating treatments for blood disorders and related complications.

  • Sickle Cell Disease Treatment
  • Iron Overload Management
  • Multiple Myeloma

Comprehensive trials investigating new therapeutic approaches for various blood disorders.

05 Neurological Conditions

Studies investigating treatments for multiple sclerosis and stroke prevention. Research focused on improving neurological outcomes and disease management.

  • Multiple Sclerosis
  • Stroke Prevention
  • Neurological Disorders

Trials evaluating innovative therapies for managing chronic neurological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.